Desipramine 150 mg Tablet is a Health Canada–registered human drug (DIN 02211998) held by Apotex Inc, containing Desipramine Hydrochloride. Health Canada lists its status as Cancelled Pre Market (status date 10 Sep 2021). Nexara Health has matched 52 registrations of Desipramine Hydrochloride across 2 other regulated markets.
Health Canada registration
| DIN | 02211998 |
|---|---|
| Brand name | Desipramine |
| Active ingredient | Desipramine Hydrochloride |
| Strength | 150 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Apotex Inc |
| Status | Cancelled Pre Market — 10 Sep 2021 |
| Class | Human |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Desipramine Hydrochloride registered in other markets
52 registrations of the same molecule in 2 national registries outside Canada (first 9 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Norpramin 25mg | Lakeside Lab. Inc. | 錠劑 | 已註銷 | TFDA | |
| United States | Desipramine HCL | Direct_Rx | Tablet | listed | FDA NDC | |
| United States | DESIPRAMINE HCl | Pcas Finland Oy | Powder | FDA NDC | ||
| United States | Desipramine Hydrochloride | Lundbeck Pharmaceuticals Italy S.p.A. | Powder | FDA NDC | ||
| United States | Desipramine Hydrochloride | Actavis Pharma, Inc. | Tablet, Film Coated | listed | FDA NDC | |
| United States | Desipramine Hydrochloride | Actavis Pharma, Inc. | Tablet, Film Coated | listed | FDA NDC | |
| United States | Desipramine Hydrochloride | Actavis Pharma, Inc. | Tablet, Film Coated | listed | FDA NDC | |
| United States | Desipramine Hydrochloride | Actavis Pharma, Inc. | Tablet, Film Coated | listed | FDA NDC | |
| United States | Desipramine Hydrochloride | Actavis Pharma, Inc. | Tablet, Film Coated | listed | FDA NDC |
See every manufacturer of Desipramine Hydrochloride worldwide →
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 02216264 | Desipramine | Aa Pharma Inc | 50 mg | Tablet |
| 02216256 | Desipramine | Aa Pharma Inc | 25 mg | Tablet |
| 02216280 | Desipramine | Aa Pharma Inc | 100 mg | Tablet |
| 02216272 | Desipramine | Aa Pharma Inc | 75 mg | Tablet |
| 02216248 | Desipramine | Aa Pharma Inc | 10 mg | Tablet |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Desipramine (DIN 02211998) marketed in Canada?
No. Health Canada lists DIN 02211998 as Cancelled Pre Market as of 10 Sep 2021.
Who holds the Canadian licence for this product?
Apotex Inc is the company of record in the Health Canada Drug Product Database.
Is Desipramine Hydrochloride registered outside Canada?
Yes — Nexara Health has matched 52 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02211998, status date 2021-09-10; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02211998, status date 2021-09-10; national medicine registries: FDA NDC, TFDA.
Health Canada Drug Product Database (DPD), DIN 02211998, status date 2021-09-10; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.